Mesoblast Limited - MESO

About Gravity Analytica
Recent News
- 09.16.2025 - Becoming a substantial holder
- 09.16.2025 - Becoming a substantial holder
- 09.15.2025 - Ceasing to be a substantial holder
- 09.14.2025 - Ryoncil Launch Highlighted at Global Healthcare Conferences
- 09.12.2025 - Change of Director's Interest Notice
- 09.12.2025 - Change in substantial holding
- 09.03.2025 - Proposed issue of securities - MSB
- 09.03.2025 - Mesoblast Option to Issue up to US$50m Convertible Notes
- 08.29.2025 - Becoming a substantial holder
- 08.28.2025 - Annual Financial Results Presentation
Recent Filings
- 09.15.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 09.15.2025 - EX-99.1 EX-99.1
- 09.15.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 09.15.2025 - EX-99.1 EX-99.1
- 09.12.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 09.04.2025 - EX-99.1 EX-99.1
- 09.04.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 08.29.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
- 08.29.2025 - 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 08.29.2025 - EX-99.1 EX-99.1